In the Original Investigation “P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent: The SHARE Randomized Clinical Trial,”1 published March 7, 2024, there was an error in Figure 1. The number of patients enrolled and randomized should have been 1452. This article has been corrected.1
References
- 1.Min PK, Kang TS, Cho YH, et al. P2Y12 inhibitor monotherapy vs dual antiplatelet therapy after deployment of a drug-eluting stent: the SHARE randomized clinical trial. JAMA Netw Open. 2024;7(3):e240877. doi: 10.1001/jamanetworkopen.2024.0877 [DOI] [PMC free article] [PubMed] [Google Scholar]